Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 1, p. 75, doi. 10.1007/s00280-013-2170-5
- By:
- Publication type:
- Article
Works by Miguel-Lillo, B.
Results: 8
1
2
Population pharmacokinetics of PM00104 (Zalypsis((R))) in cancer patients.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
3
Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
4
Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1397, doi. 10.1007/s00280-011-1612-1
- By:
- Publication type:
- Article
5
Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects.
- Published in:
- 2009
- By:
- Publication type:
- journal article
6
Pooled analysis of three pharmacokinetic studies comparing biosimilar MB02 and reference bevacizumab.
- Published in:
- Pharmacology Research & Perspectives, 2023, v. 11, n. 6, p. 1, doi. 10.1002/prp2.1139
- By:
- Publication type:
- Article
7
Population pharmacokinetic-pharmacodynamic analysis of neutropenia in cancer patients receiving PM00104 (Zalypsis(®)).
- Published in:
- 2012
- By:
- Publication type:
- journal article
8
Pharmacokinetics and excretion of C-Plitidepsin in patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 5, p. 589, doi. 10.1007/s10637-017-0432-5
- By:
- Publication type:
- Article